Founded
31 Dec 2000
VCID: 346796
Profile
Corporate information
Registration country
Investment activity status
Active investor
Company type
Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseasesFunding
Funding rounds
(1 Aug 2003)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
MPM Capital | United States | Initial investment. Round participant. | |
|
Prospect Venture Partners | Venture capital firm | United States | Initial investment. Round participant. |
|
Schroder Ventures Life Sciences Inc | United States | Initial investment. Round participant. | |
|
Essex Woodlands Health Ventures Inc | United States | Follow-on investment. Round participant. | |
|
|
Technology Partners. | Venture capital firm | United States | Follow-on investment. Round participant. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Essex Woodlands Health Ventures Inc | United States | Initial investment. Round participant. | |
|
|
Technology Partners. | Venture capital firm | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Essex Woodlands Health Ventures Inc |
+1 (281) 364-1555 |
Series A Series B |
|
|
MPM Capital |
+1 (650) 553-3300 |
Series B |
|
|
Prospect Venture Partners Venture capital firm |
+1 (650) 327-8800 |
Series B |
|
|
Schroder Ventures Life Sciences Inc |
Series B | |
|
SV Health Investors LLP |
N/A (exited) | |
|
|
Technology Partners. Venture capital firm |
+1 (650) 289-9000 |
Series A Series B |